4.7 Article

The melanocortin MC1 receptor agonist BMS-470539 inhibits leucocyte trafficking in the inflamed vasculature

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Role of adiponectin and inflammation in insulin resistance of Mc3r and Mc4r knockout mice

James L. Trevaskis et al.

OBESITY (2007)

Review Biochemistry & Molecular Biology

Resolution of inflammation: state of the art, definitions and terms

Charles N. Serhan et al.

FASEB JOURNAL (2007)

Review Pharmacology & Pharmacy

Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders?

Elena Gonzalez-Rey et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2007)

Review Immunology

Regulation of immune tolerance by anti-inflammatory neuropeptides

Elena Gonzalez-Rey et al.

NATURE REVIEWS IMMUNOLOGY (2007)

Review Immunology

Getting to the site of inflammation: the leukocyte adhesion cascade updated

Klaus Ley et al.

NATURE REVIEWS IMMUNOLOGY (2007)

Article Gastroenterology & Hepatology

Crucial role of the melanocortin receptor MC1R in experimental colitis

C. Maaser et al.

Review Pharmacology & Pharmacy

Targeting melanocortin receptors as potential novel therapeutics

Stephen J. Getting

PHARMACOLOGY & THERAPEUTICS (2006)

Article Biochemistry & Molecular Biology

Melanocortin receptor signaling in RAW264.7 macrophage cell line

CW Lam et al.

PEPTIDES (2006)

Review Immunology

Resolution of inflammation: The beginning programs the end

CN Serhan et al.

NATURE IMMUNOLOGY (2005)

Review Biotechnology & Applied Microbiology

Inflammatory resolution: New opportunities for drug discovery

DW Gilroy et al.

NATURE REVIEWS DRUG DISCOVERY (2004)

Review Pharmacology & Pharmacy

Targeting melanocortin receptors as a novel strategy to control inflammation

A Catania et al.

PHARMACOLOGICAL REVIEWS (2004)

Review Endocrinology & Metabolism

α-melanocyte-stimulating hormone in normal human physiology and disease states

A Catania et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2000)